Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
OtherArticle

Key amino acid residues responsible for the differences in substrate specificity of human UDP-glucuronosyltransferase (UGT) 1A9 and UGT1A8

Ryoichi Fujiwara, Miki Nakajima, Hiroyuki Yamanaka and Tsuyoshi Yokoi
Drug Metabolism and Disposition October 2, 2008, DOI: https://doi.org/10.1124/dmd.108.022913
Ryoichi Fujiwara
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Miki Nakajima
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hiroyuki Yamanaka
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tsuyoshi Yokoi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

DOI 
https://doi.org/10.1124/dmd.108.022913
PubMed 
18832479

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X

Article Versions

  • You are currently viewing an Earlier version of this article (October 2, 2008 - 08:37).
  • View the most recent version of this article

Author Information

Statistics from Altmetric.com

Article usage

Article usage: October 2008 to February 2021

AbstractFullPdf
Oct 2008500109
Nov 200822054
Dec 200837239
Jan 2009182037
Feb 2009241616
Mar 2009171411
Apr 2009131623
May 2009141010
Jun 2009487
Jul 2009131612
Aug 20091279
Sep 2009111417
Oct 200918811
Nov 20091212
Dec 20092310
Jan 2010511219
Feb 20103089
Mar 2010491120
Apr 201036811
May 20103838
Jun 201040617
Jul 20103788
Aug 20104554
Sep 2010111010
Oct 2010321613
Nov 201027129
Dec 201031912
Jan 201116912
Feb 2011241112
Mar 201125127
Apr 20111458
May 2011191013
Jun 201117916
Jul 2011281111
Aug 201130410
Sep 2011351119
Oct 201125816
Nov 201144713
Dec 20111599
Jan 20122497
Feb 20122874
Mar 201268149
Apr 20124244
May 201231912
Jun 20122969
Jul 201243711
Aug 2012571615
Sep 201224413
Oct 201227914
Nov 2012401618
Dec 201223513
Jan 2013281111
Feb 201356188
Mar 2013231114
Apr 2013612127
May 2013391113
Jun 20132684
Jul 20133453
Aug 20131953
Sep 201339116
Oct 20133151
Nov 20132692
Dec 201327618
Jan 20141561
Feb 20142843
Mar 20142946
Apr 2014251311
May 20142277
Jun 20142445
Jul 20142042
Aug 20141773
Sep 201422210
Oct 201487124
Nov 20141694
Dec 20143149
Jan 20153057
Feb 20151633
Mar 20151841
Apr 20152541
May 20151812
Jun 20151695
Jul 20153067
Aug 20152665
Sep 20152232
Oct 20151432
Nov 20159515
Dec 20151363
Jan 20161446
Feb 201610106
Mar 20169110
Apr 2016852
May 201612410
Jun 201611617
Jul 201610120
Aug 201612210
Sep 201613415
Oct 20163136
Nov 2016147
Dec 2016864
Jan 20172137
Feb 2017187
Mar 20171187
Apr 201701512
May 20170156
Jun 2017052
Jul 2017160
Aug 20171164
Sep 20170232
Oct 20170166
Nov 20171228
Dec 20170178
Jan 201801410
Feb 20180122
Mar 20180294
Apr 20180360
May 20181286
Jun 20180253
Jul 20180101
Aug 20180163
Sep 20180185
Oct 2018061
Nov 2018080
Dec 2018912
Jan 2019402
Feb 20191902
Mar 20191313
Apr 20191004
May 2019213
Jun 2019706
Jul 2019904
Aug 20191401
Sep 20191600
Oct 20191712
Nov 20191400
Dec 20191322
Jan 20201332
Feb 20201421
Mar 20201100
Apr 2020700
May 20209014
Jun 2020600
Jul 20201000
Aug 2020629
Sep 20201202
Oct 20201502
Nov 20201201
Dec 20202122
Jan 20211374
Feb 20211783

Next
Back to top

In this issue

Drug Metabolism and Disposition: 49 (3)
Drug Metabolism and Disposition
Vol. 49, Issue 3
1 Mar 2021
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Key amino acid residues responsible for the differences in substrate specificity of human UDP-glucuronosyltransferase (UGT) 1A9 and UGT1A8
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
OtherArticle

Key amino acid residues responsible for the differences in substrate specificity of human UDP-glucuronosyltransferase (UGT) 1A9 and UGT1A8

Ryoichi Fujiwara, Miki Nakajima, Hiroyuki Yamanaka and Tsuyoshi Yokoi
Drug Metabolism and Disposition October 2, 2008, DOI: https://doi.org/10.1124/dmd.108.022913

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
OtherArticle

Key amino acid residues responsible for the differences in substrate specificity of human UDP-glucuronosyltransferase (UGT) 1A9 and UGT1A8

Ryoichi Fujiwara, Miki Nakajima, Hiroyuki Yamanaka and Tsuyoshi Yokoi
Drug Metabolism and Disposition October 2, 2008, DOI: https://doi.org/10.1124/dmd.108.022913
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • In Vivo Functional Effects of CYP2C9 M1L
  • Clearance pathways: fevipiprant with probenecid perpetrator
  • Predicting Volume of Distribution from In Vitro Parameters
Show more Article

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics